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Abstract
The influence of genetic variability within the major histocompatibility complex (MHC) region on 
variations in immune responses to childhood vaccination was investigated. The study group 
consisted of 135 healthy infants who had been immunized with hepatitis B (HBV), 7-valent 
pneumococcal conjugate (PCV7), and diphtheria, tetanus, acellular pertussis (DTaP) vaccines 
according to standard childhood immunization schedules. Genotype analysis was performed on 
genomic DNA using Illumina Goldengate MHC panels (Mapping and Exon Centric). At the 1 year 
post vaccination check-up total, isotypic, and antigen-specific serum antibody levels were 
measured using multiplex immunoassays. A number of single nucleotide polymorphisms (SNPs) 
within MHC Class I and II genes were found to be associated with variations in the vaccine 
specific antibody responses and serum levels of immunoglobulins (IgG, IgM) and IgG isotypes 
(IgG1, IgG4) (all at p< 0.001). Linkage disequilibrium patterns and functional annotations showed 
that significant SNPs were strongly correlated with other functional regulatory SNPs. These SNPs 
were found to regulate the expression of a group of genes involved in antigen processing and 
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presentation including HLA-A, HLA-C, HLA-G, HLA-H, HLA-DRA, HLA-DRB1, HLA-DRB5, 
HLA-DQA1, HLA-DQB1, HLA-DOB, and TAP-2. The results suggest that genetic variations 
within particular MHC genes can influence immune response to common childhood vaccinations, 
which in turn may influence vaccine efficacy.
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1. Introduction
Even with uniform administration schemes, large inter-individual variability exists in 
vaccine responsiveness among vaccine recipients. For example, 5–20% and 2–10% of 
healthy individuals experience either hypo- or non-responsiveness to hepatitis B (HBV) or 
measles vaccination, respectively [1–4]. A strong genetic component has been demonstrated 
in the regulation of immune responses to the vaccines. A number of polymorphisms have 
been reported to be associated with vaccine responsiveness including variants of the major 
histocompatibility complex (MHC) [5–7] and cytokine and cytokine receptor genes [8–11].
The MHC spans ~4Mb and comprises over 180 protein-coding genes, many of which 
determine immune function, susceptibility to complex diseases, and transplant rejection. 
MHC class II molecules are involved in the presentation of MHC-peptide complexes on the 
surface of antigen presenting cells to CD4+ T cells. These molecules are highly polymorphic 
and this diversity helps determine immune recognition. Along with the HLA genes, several 
functionally important genes are located in this region including those that code for 
complement proteins C4, C2 and Factor B, the cytokines tumor necrosis factor α and β and 
TAP (antigen peptide transporter) that function in antigen processing [12,13].
The contribution of the MHC variants to the vaccine immune response was first observed by 
a significant excess of HLA-DR7 and a total absence of HLA-DR1 in individuals that failed 
to respond to hepatitis B vaccine [14]. Subsequent studies revealed associations between 
certain HLA class II (HLA-DR, HLA-DQ) alleles and poor or non-immune response to 
HBV [6,9,15–19]. In addition, poor responsiveness to hepatitis B vaccine was associated 
with extended MHC haplotypes such as B8-DR3-SC01, B44-DR7-FC31 and B18-
DRB1*0301-DQB1*0201 [6,15,18–20]. Several studies have also demonstrated the 
influence of HLA allelic variation on immune response to measles, mumps, rubella, and 
influenza vaccines [21–24]. For example, HLA class I B*8, B*13, and B*44 alleles were 
associated with IgG seronegativity after a single dose of measles vaccine whereas the A*29-
C*16-B*44 haplotype was associated with low IgG antibody levels after two doses of the 
same vaccine [21,25]. The DPA1*0201 and DPB1*0401 alleles were associated with low 
and high levels of rubella-induced antibodies in two separate cohorts, respectively [26]. 
Furthermore, the DRB1*04-DQB1*03-DPB1*03 and DRB1*15/16-DQB1*06-DPB1*03 
haplotypes were associated with low levels of rubella-specific antibodies [23].
Although the HLA complex is one of the most extensively studied regions in the human 
genome, the other genes in the MHC region have not yet been well investigated with regard 
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to vaccine responsiveness. In the present study, a focused approach has been taken to 
examine the association of SNPs within the MHC region with variation in childhood vaccine 
responses.
2. Materials and methods
2.1. Study population and vaccinations
Study procedures were approved by the Institutional Review Boards of all participating 
institutions. The subjects were infants seen in two University-affiliated general pediatrics 
clinics for routine 1 year old checkup examinations. These clinics routinely obtained blood 
by finger stick during the 1 year checkup to screen for anemia and lead poisoning. If parents 
gave informed consent, additional tubes of blood for genomic DNA were obtained. In 
addition, immunization records were reviewed to document history of immunization with 
HBV (Recombivax®, Merck&Co., Inc., White-house Station, NJ); DTaP (Daptacel®, Sanofi 
Pasteur, Ontario, CA); heptavalent pneumococcal conjugate vaccine (PCV7-serotypes 4, 6B, 
9V, 14, 18C, 19F, 23F) (Prevnar®, Wyeth, Philadelphia, PA); inactivated polio vaccine 
(IPV); and Haemophilus influenza type b (Hib) conjugate vaccine in accordance with then-
current guidelines for childhood immunization [27]. A total of 135 healthy infants, aged 
11.5–14 months of age (mean: 12.6 months), were recruited into the study. The majority of 
children were non-Hispanic whites (121) and male (77). The demographics and 
immunological variables of the participants that were included in the analysis are given in 
Table 1.
2.2. Genotyping
Genomic DNA was extracted from whole blood samples using the QIAamp blood kit 
(QIAGEN Inc., Chatsworth, CA). Genotyping was performed according to the standard 
protocol provided by Illumina using the MHC Panel Set and Golden Gate protocol (Illumina 
Inc., San Diego, CA). The MHC SNP set consisted of two oligonucleotide pools, MHC 
Mapping Panel and MHC Exon-Centric Panel for 1228 and 1293 SNP loci, respectively. 
Both panels cover 2360 independent loci spaced at an average of 2.08 kb (range: 0.005–
71.05 kb). Genotyping was performed in a 16-well format using universal BeadChips. A 
total of 250 ng to 1 µg DNA was used for each assay depending on the source. Genotypes 
were auto called using GenomeStudio software (Illumina, Inc., San Diego, CA).
2.3. Microsphere coupling
Pneumococcal polysaccharides (PnPS) were obtained from ATCC, Manassas, VA. 
Pneumococcal cell wall polysaccharide (CPS) was obtained from Staten Serum Institute 
(Copenhagen, Denmark). Diphtheria and tetanus toxoids were obtained from University of 
Massachusetts Biologics Laboratories, Jamaica Plain, MA. The PnPSs were conjugated to 
spectrally distinguishable microspheres (Luminex, Austin, TX) using 4-(4,6-
dimethoxy[1,3,5]triazin-2-yl)-4-methyl-morpholinium [28]. Diphtheria and tetanus toxoids 
were conjugated to spectrally distinguishable microspheres using 1-ethyl-3-(3-
dimethylaminopropyl)-carbodiimide hydrochloride and sulfo-N-hydroxysuccinimide [28].
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2.4. Serum collection and analyses
Blood samples were collected at approximately 1 year of age (mean: 12.6 months). Serum 
was isolated and stored at −20 °C until analysis. Vaccine-specific antibody responses to 
PnPSs, diphtheria and tetanus toxoids; and total serum immunoglobulin levels (IgM, IgA, 
IgG and IgG subclasses) were measured by multiplex assay as previously described [29,30]. 
Briefly, microspheres coupled to PnPSs, diphtheria and tetanus toxoids were mixed and 
added to standards and samples diluted in PBS containing 1%BSA, 0.05%Tween 20, 10 
µg/ml of CPS, and 100 µg/ml of PnPS 22. Measurement and data analysis were performed 
using the Bioplex multiplex testing platform (BioRad, Hercules, CA). Assays were 
performed in duplicate. Serum concentrations of IgG, IgA, IgM, and IgG subclasses were 
measured in duplicate using Beadlyte® assay according to the manufacturer’s instructions 
(Upstate, Lake Placid, NY).
Levels of specific serum antibody to HBsAg were determined using a commercially-
available enzyme immunoassay according to the manufacturer’s instructions (ETI-AB-AUK 
PLUS, DiaSorin Inc., Stillwater, MN). All serum measurements were above the minimum 
detection limit of the assay.
2.5. Statistical analyses
SNP-specific deviations from the Hardy-Weinberg Equilibrium were tested using chi-
squared goodness-of-fit tests. Antibody levels were transformed to their log values (base 2) 
before analysis to fit the normality assumptions. These variables were included in the 
analysis first as continuous variables then they were turned into binary variables at 
thresholds of 10% and 15% to examine the trend in data.
The genotype confidence score of the assay was set to 0.25 in GenomeStudio Genotyping 
module. Alleles that were not called in a sample were coded as missing in the analysis. For 
missing rates per individual and per SNP, a threshold of 2% was used. Datasets from exon-
centric and mapping panels were merged using PLINK [31]. This dataset contained 1856 
SNPs for 135 subjects including 77 males and 58 females. The initial two datasets had 111 
markers in common and the concordance rate of these markers was 0.999. Initial datasets 
had 124 subjects in common thus, 11 subjects had set of markers either from exon-centric or 
mapping panels. The total genotype rate for the merged dataset was 0.96. Replicate sample 
comparisons within and across DNA genotyping plates also demonstrated high agreement 
(data not shown).
Statistical analysis was performed using PLINK version 1.07 [31]. Linear and logistic 
regression models, with adjustments for gender, age and ethnicity, were used to test for 
differences between antibody levels (as continuous and binary data) according to genotypes. 
Associations were tested individually and based on principal components determined from 
combinations of antibody levels. Linkage disequilibrium (LD) and haplotype blocks were 
assessed using default parameters in Haploview [32]. Pairwise LD was calculated only for 
SNPs within 200 kb. SNAP was used to find proxy SNPs within 500 kb based on LD and 
physical distance [33]. RegulomeDB was used to annotate SNPs with known and predicted 
regulatory elements [34].
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All analyses were conducted on both the quantitative antibody phenotype and the 
dichotomized serotype status (lowest 10% and 15%). Since discretization could result in 
arbitrary cut-off levels, the focus of this report will be on the results with the quantitative 
phenotypes. However, the results for both analyses were consistent with each other 
(overlaps with the binary analysis are marked in Tables 2 and 3).
3.1. Association between vaccine specific antibody responses and SNPs
1856 SNPs in 154 genes were studied for their influence on vaccine induced serum antibody 
levels. All genotype frequencies were in Hardy Weinberg Equilibrium. After adjusting for 
gender, age and ethnicity, several SNPs were significantly associated with vaccine specific 
antibody responses. Table 2 summarizes these associations and provides p values calculated 
in an additive manner. The RPP21 (rs3129820 and rs6936217), ZBTB12 (rs558702), BF 
(rs1270942), STK19 (rs389884), TNXB (rs1150758, 1150753), CREBL1 (rs1269852), 
NOTCH4 (rs3134942 and rs3131296), BTNL2 (rs3129950), HLA-DRA (rs984778, 
rs3135338, rs3135395 and rs2395178) and HLA-DQA1 (rs2187668) SNPs were 
significantly associated with variations in median anti-HBsAg antibody levels (p< 0.001). In 
addition, the GG genotype of the PSORS1C1 rs3130454 SNP was associated with a lower 
serum antibody levels to tetanus (p< 0.001). Regarding antibody response to PCV7, the 
HLA-DOB (rs2857130, rs2857127, rs6929716, rs7383433, rs5009557) and TAP2 
(rs1015166) SNPs were associated with significant variations in PnPS4 (p< 0.001) serotype 
specific antibody titers. The HLA-DOB rs5009557 SNP was also associated with variation 
in PnPS9V serotype level. The GG genotype of LEMD2 rs755495 SNP was associated with 
higher serum antibody levels to serotype PnPS14 (p<0.001). SNPs in the COL11A2 
(rs9368758, rs2269346), HSD17B8 (rs383711), RING1 (rs213210) were associated with 
variations in PnPS19F serotype-specific antibody titers (p < 0.001) while the NOTCH4 
SNPs (rs2071280, rs2071287, rs2071277) were associated with altered response to PnPS23F 
serotype. Manhattan plots showing the association signals for each vaccine (and serotype) 
are provided in Supplementary Fig. 1. None of the other polymorphisms that were examined 
showed any significant association with immune responses to vaccine antigens.
Supplementary material related to this article can be found, in the online version, at http://
dx.doi.org/10.1016/j.vaccine.2013.09.026.
3.2. Association between immunoglobulin levels and SNPs
Significant associations (p < 0.001) were observed between certain SNPs and serum 
concentrations of IgM, IgG, and IgG subclasses (Table 3). Total IgG and IgG1 subclass 
levels significantly effected in subjects with HLA-F and FLJ35429 SNPs while IgG4 levels 
varied significantly by the BTNL2 and C6orf10 SNPs (<0.001). The HLA-G, HLA-C, HLA-
DRA, HCG9, FLJ35429, MAS1L, OR2W1, OR2J3, OR2J2, OR2H1, OR5U1, OR10C1, 
RFP, RFN39 and TRIM39 SNPs were significantly associated with variations in IgM levels 
(p< 0.001). Manhattan plots showing the association signals for each Ig class and subclass 
are given in Supplementary Fig. 2. There was no significant association between serum IgA 
levels and any of the tested SNPs.
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Supplementary material related to this article can be found, in the online version, at http://
dx.doi.org/10.1016/j.vaccine.2013.09.026.
3.3. Association between antibody levels and principal components
In order to reduce data dimensionality, we performed principal component analysis (PCA). 
Immune responses were categorized into two groups. The first group consisted of vaccine 
specific antibody responses (10 variables) and the second group included Ig levels (7 
variables). A number of significant associations were identified between individual principal 
components and genotypes (Supplementary Table 1). SNPs that were significant in both 
linear regression and PCA are marked in Tables 2 and 3.
Supplementary material related to this article can be found, in the online version, at http://
dx.doi.org/10.1016/j.vaccine.2013.09.026.
3.4. Association between antibody levels and haplotypes
A number of significant associations were identified between inferred haplotypes and 
vaccine-induced immune responses both in continuous and binary analyses. Table 4 shows 
haplotype frequencies and significant associations. Variation in median anti-HBsAg levels 
was significantly associated with ten haplotypes. The first haplotype included 11 SNPs that 
were mapped to the RPP21 gene. Two of these SNPs (rs3129820 and rs6936217) were also 
significant in linear regression analysis. Four of the other haplotypes also included SNPs 
that showed individual associations with immune response to hepatitis B vaccine. These 
haplotypes consisted of SNPs in the ZBTB12, BF, TNXB, and NOTCH4 genes. Variation in 
PnPS4 antibody level was associated with the haplotype that contained five SNPs also 
identified in the linear regression analysis. All these SNPs were mapped to the HLA-DOB 
gene. The haplotype correlated with variability in PnPS19F level was constructed by SNPs 
that were mapped to COL11A2, RXRB, SLC39A7, HSD17B8 and RING1 genes. However, 
only SNPs mapped to COL11A2, HSD17B8 and RING1 genes were individually associated 
with PnPS19F levels. Both NOTCH4 SNP and haplotype that included this SNP were 
associated with variation in PnPS23F serotype level. Haplotypes containing SNPs that 
showed individual associations are displayed in bold in Table 4.
Significant associations were also observed between certain haplotypes and serum 
immunoglobulin levels (Table 4). Many SNPs constructing these haplotypes were also 
identified in the linear regression analysis. Haplotypes consisting of FLJ35429 and BTNL2 
SNPs were significantly associated with variation in IgG, IgG1 and IgG4 levels. Variability 
in serum IgM levels was associated with 15 haplotypes. Only four of them did not include 
SNPs that were identified in the linear regression analysis.
3.5. Regulatory information for significant associations
The 76 unique significant SNPs identified from initial analyses were used as inputs to the 
SNP Annotation and Proxy Search (SNAP) tool [33] to find additional SNPs in complete 
linkage disequilibrium (using an r2 of 1). This led to the identification of an additional 149 
perfectly correlated SNPs using data from the International HapMap Project [35]. The total 
set of 225 SNPs was then used as inputs to the RegulomeDB [34] web resource, which 
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integrates data from the ENCODE projects and other data sources regarding various types of 
functional assays including DNaseI-seq, ChIP-seq, RNAseq, and eQTL analyses. 
Coordinates of both significant and correlated SNPs were derived from hg19 to ensure that 
they match the locations of variants in RegulomeDB. SNPs with RegulomeDB scores 
between 1 and 3 (inclusive, where scoring refers to available datatypes supporting a 
functional role for the variant) and related genes are listed in Table 5.
4. Discussion
Consistent with previous studies, the present study demonstrates that MHC region variants 
significantly contribute to vaccine-specific antibody responses in a relatively specific and 
predictable manner. The MHC region exhibits high levels of allelic diversity and extensive 
patterns of LD encompassing multiple genes involved in immunity. The MHC class II 
molecules were extensively studied in relation to vaccine induced immune responses and 
their variations were found to be associated with altered antibody production against the 
presented antigen [36–38]. However, very little is published on vaccine-induced 
immunogenicity regarding genetic variation in other parts of the MHC region [7]. Since the 
significant association signals may tag nearby functional SNPs due to high levels of LD 
within the region, we identified highly correlated SNPs within 500 kb and assessed their 
regulatory potential. This analysis showed that significant signals from different regions of 
the MHC are correlated with SNPs that control the expression of a small number of genes 
involved in antigen processing and presentation.
Previous reports demonstrated that the immune response to hepatitis B vaccine is largely 
determined by HLA-DR and HLA-DQ alleles [9,17,39]. Certain HLA class II alleles were 
associated with high (DRB1*01, DRB1*11, DRB1*15, DQB1*0501, DPB1*0401) and poor 
or non-response to HBV (DRB1*03, DRB1*07, DQB1*02, DPB1*1101). In line with these 
observations, we found HLA-DR and HLA-DQ SNPs to be significantly associated with the 
variations in median anti-HBsAg antibody levels. HLA-DRA rs3135395, rs3135338, and 
rs984778 SNPs were in strong LD. Functional annotation of SNPs using RegulomeDB 
showed that these SNPs regulate the expression level of genes including HLA-DRA, HLA-
DQA1, HLA-DRB1, HLA-DRB5 and ERG. Similarly, HLA-DQA1 rs2187668 SNP had a 
regulatory effect on HLA-DQA1, BTN3A2, HLA-A, HLA-DPB1, HLA-DQB1, HLA-
DRB1 and HLA-DRB5 genes. Interestingly, the HLA-DQA1 gene was also regulated by 
NOTCH4 SNPs (rs3131296 and rs3134942) and two highly correlated TNXB (rs1150752, 
rs1150753) SNPs. We were not able to find regulatory information for RPP21 rs3129820 
and rs6936217 SNPs, but both of them were highly correlated with two SNPs (rs3129822 
and rs3094035) that affect the expression of HLA-A, BNTN3A2, HLA-C, HLA-DQA1, 
HLA-DQB1, HLA-DRB1, HLA-G and HLA-H genes. The role of other genes has not been 
extensively characterized in the context of vaccine immunity.
SNPs mapped to the HLA-DOB, TAP2, COL11A2, LEMD2, HSD17B8, RING1 and 
NOTCH4 genes were associated with the variations in immune response to PnPS serotypes. 
Five SNPs mapping to the HLA-DOB gene were associated with PnPS4 serotype and 
interestingly, they were correlated with the same SNP (rs2067577) that affects the regulation 
of HLA-DOB, HLA-DRB5 and TAP-2 genes. HLA-DR plays a central role in the 
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presentation of peptides on the cell surface for T-cell recognition. HLA-DOB is an 
important modulator in the HLA class II restricted antigen presentation pathway by 
interaction with the HLA-DM molecule in B-cells. The transporter associated with antigen 
processing (TAP) gene, a member of the ATP-binding cassette transporter super family, is 
involved in the processing of endogenous peptides that bind to MHC class I molecules [40]. 
It has been suggested that TAP polymorphisms may cause differential antigen processing 
and thereby influence antigen presentation by MHC molecules. TAP2 allelic variants have 
also been found associated with measles antibody response [41,42]. Based on their role in 
the process of the immunogenic peptides, it is plausible that genetic variability within HLA-
DOB, HLA-DR and TAP-2 genes may affect the efficiency of antigen presentation and 
thereby vaccine immunogenicity. Two highly linked NOTCH4 SNPs (rs2071287 and 
rs2071277) showed significant association with PnPS23F serotype in linear regression 
analysis. Notably, these two SNPs were also associated with the third principal component 
of vaccine specific antibody group. The RegulomeDB database showed that the rs2071287 
SNP has a regulatory effect on HLA-DQA1 and HLA-DQB1 genes. There are no previous 
studies reporting association between MHC SNPs and antibody levels to diphtheria. In line 
with this, we did not find any association between SNPs and diphtheria induced immune 
responses in our population. This could be related to the nature of the vaccine, as toxoid 
vaccines tend not to be highly immunogenic.
A large number of SNPs were associated with total serum Ig levels and mapped to BNTL2, 
RFP, OR2W1, OR2J3, OR2J2, OR5U1, OR10C1, OR2H1, MAS1L, FLJ35429, HLA-F, 
HLA-G, HCG9, RFN39, TRIM39, HLA-C and HLA-DRA genes. In the association 
analysis, the variations in median IgM, IgG and IgG1 levels were significantly associated 
with FLJ35429 and HLA-F linked SNPs. RegulomeDB showed that the FLJ35429 
rs1611350 SNP affects the regulation of BTN3A2, HLA-A and ZFP57 genes. The function 
of the BTN3A2 and ZFP57 genes in immune response is yet unknown. Although no 
regulatory information exists for the HLA-F SNPs (rs1628578 and rs2517911), both variants 
were in strong LD with another HLA-F SNP rs1632967, which affects the expression of 
HLA-G. HLA-A and HLA-G are non-classical class I proteins that play a central role in 
antigen presentation and immunomodulation [43,44]. HLA-G and its polymorphic sites have 
been associated with susceptibility to viral infections and autoimmune diseases [45,46]. 
These three SNPs (rs1611350, rs1628578 and rs2517911) were associated with IgG1, IgG 
and IgM levels suggesting that genetic variability at these loci may play role in the 
quantitative regulation of other antibody responses and represent plausible candidate genetic 
modifiers of vaccine immunity.
Two SNPs mapped to the OR2J2 (rs3116830) and RFP (rs3118361) genes were associated 
with IgM levels and found to be correlated with the same five SNPs (rs3130893, rs3129791, 
rs3130837, rs3130845 and rs3131073) that affect HLA-A gene expression. The TRIM39 
(rs3130380) and RNF39 (rs9261290) SNPs that were associated with IgM levels were also 
found to influence HLA-A gene regulation. Six IgM-associated SNPs mapped to the HLA-
DRA gene and their correlated SNPs were found to be affecting the regulation of HLA-
DRB5, HLA-DQB1 and HLA-DQA1 genes. Results from PCA analysis showed that the 
second principal component of Ig group was associated with SNPs mapped to the RFP, 
OR2W1, OR2J3 and OR2J2 genes. Some of the SNPs that overlapped with the SNPs 
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identified in the linear regression analysis (except rs381808) were also significant in logistic 
regression analysis with binary cut-off 15%. This might be explained by the fact that some 
SNPs were mapped to the same genes or haplotypes or they were physically close to each 
other to show association as a group.
The majority of the haplotype associations were related to the variations in median anti-
HBsAg and IgM levels. Although some SNPs within the blocks mapped to genes involved 
in antigen presentation (HLA-A, HLA-G, HLA-DOB, TAP-2), most mapped to genes with 
unidentified immune functions (e.g., FLJ35429, C6orf15, RFP, OR5U1). Some of the 
haplotypes included SNPs that were also identified in the linear regression analysis. This 
might be due to a strong correlation between SNPs that construct the haplotype. Either high 
LD between SNPs caused the association to spread across the haplotype or strong 
association with the haplotypes let individual SNPs to be significant. SNPs identified only in 
linear regression analysis were possibly not included in any of the haplotypes or haplotypes 
including these SNPs did not reach statistical significance (p< 0.001). This is also true for 
the identified haplotypes that did not contain any significant SNPs from the regression 
analysis. Overall, strong association with certain haplotypes and individual SNPs that 
construct these haplotypes suggest that genetic variability in this region is strongly 
correlated with altered immune responses.
This is the first study reporting associations between SNPs within the entire MHC and 
immune response to childhood vaccines and suggests that this region is likely to contain a 
number of genes that affect vaccine responsiveness. The results were not corrected for 
multiple comparisons since our analysis was based on the well-defined role of the MHC in 
immune responses. Instead, we reported all tests that reached a p< 0.001 level of 
significance and focused on the functional relevance of SNPs associated with vaccine 
specific responses. Although functional annotation of SNPs was supported by experimental 
regulatory data, the significance of these findings requires further validation. Replication in 
independent samples, fine mapping and functional studies may reveal the genetic 
mechanisms underlying these associations. More importantly, pathways/allelic variants 
identified through genetic studies may help the development of more uniformly effective 
next-generation vaccine formulations that could improve vaccine immunogenicity and 
efficacy.
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HBsAg surface antigen of hepatitis B virus
HBV hepatitis B virus
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Table 1
Demographic characteristics and immunological variables of the study population.
N=135
Demographics
Age (mean months, range) 12.6 (11.5–14)
Gender (F/M) 58/77
Ethnicity (non-hispanic whites/others) 121/14
Antibody levels Median Mean CI (95%)
HBV(mIU/ml) 153 499.93 290.34,709.51
Diphteria(IU/ml) 0.32 0.56 0.45,0.66
Tetanus (IU/ml) 0.2 4.1 −1.43,9.63
PnPS4 (µg/ml) 1.3 2.7 2.02,3.39
PnPS6B (µg/ml) 3.17 10.77 5.48,16.06
PnPS9V (µg/ml) 3.3 18.04 9.02,27.06
PnPS14 (µg/ml) 2.45 5.5 3.42,7.57
PnPS18C (µg/ml) 2.24 5.67 3.74,7.6
PnPS19F(µg/ml) 2.37 24.8 2.27,47.33
PnPS23F(µg/ml) 4.01 52.02 19.42,84.62
IgG (mg/dl) 639.1 701.89 648.48,755.31
IgG1 (mg/dl) 653.1 710.36 651.19,769.52
IgG2 (mg/dl) 66.4 105.27 82.83,127.71
IgG3 (mg/dl) 34 40.96 36.68,45.24
IgG4 (mg/dl) 2 24.01 6.41,41.61
IgM (mg/dl) 141.6 150.68 139.45,161.91
IgA (mg/dl) 6 6.93 6.17,7.69

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Vaccine. Author manuscript; available in PMC 2015 November 10.
